Analyst Recommendations

105.20 0.43(0.41%)09/16/2024
Ligand Pharmaceuticals, Inc. (LGND)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy9
Outperform2

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades